Top Markets
Coin of the day
BioVaxys Technology Corp. BioVaxys Technology Corp.

BioVaxys Technology Corp.

BIOV
Rang in aandelen #37710
BioVaxys Technology Corp. is a clinical-stage biotechnology company... BioVaxys Technology Corp. is a clinical-stage biotechnology company specializing in the development of vaccine platforms designed to combat both viral infections and cancer. The company's pipeline includes BVX-0320, a single-strain vaccine for SARS-CoV-2, and BVX-0918A, an experimental haptenized tumor cell vaccine targeting ovarian cancer. Additionally, BioVaxys offers CoviDTH, an immunodiagnostic tool to detect immune system activity in SARS-CoV-2-exposed patients. Further initiatives encompass Papilocare, aimed at HPV-dependent cervical lesions, along with BVX-0918C for cervical cancer, the HPV viral vaccine BVX-0204, and BVX-0121, a multivalent SARS-CoV-2 vaccine. BioVaxys has established strategic collaborations, such as a bioproduction agreement with WuXi Biologics Limited to manufacture SARS-CoV-2 s-proteins crucial for BVX-0320 and CoviDTH. It also holds a research partnership with The Ohio State University, Wexner School of Medicine, focusing on BVX-0320, and has engaged Bioanalytical Systems, Inc. for preclinical toxicology evaluations of its CoviDTH immunodiagnostic. The company is headquartered in Vancouver, Canada.
Aandeelprijs
$0.05137558
Laatst gesynchroniseerd: 2026-06-01
Marktkapitalisatie
$1.50M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
-71.60%
Land
CA
Handel BioVaxys Technology Corp. (BIOV)

Categorie

Koersgeschiedenis voor BioVaxys Technology Corp. (BIOV)
Hoogste slotkoers: $0.05 op 2026-06-01

Laagste slotkoers: $0.43 op 2018-11-01
Koersgeschiedenis van BioVaxys Technology Corp. van 2018 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) -17.58%
2025 -62.92%
2024 170.02%
2023 -84.82%
2022 -43.00%
2021 -5.87%
2020 507.75%
2019 -27.50%
2018 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE